Home » News » CROs/Service Providers » Chiltern Acquisitions Contribute to 44% Revenue Increase

Chiltern Acquisitions Contribute to 44% Revenue Increase

Friday, July 17, 2009

Chiltern International reported a 44% revenue increase for the year ended March 31, 2009, due in large part to acquisitions. The UK-based CRO attributed 15% of its growth to acquisitions, including the recent acquisition of Brazil CRO Vigiun.

Chiltern’s revenues were 73.7 million pounds ($120.9 million), compared with 51.2 million pounds for year ended March 31, 2008. The CRO’s operating profit was 244,000 pounds ($400K), compared with a loss of 1.1 million pounds in 2008.

Commenting on the results, Chiltern CEO Glenn Kerkhof said,”We are growing significantly faster than the sector average … We continue to develop and deepen our experience and expertise in each of our business units and expand our geographic network. We look forward to another year of progress despite the difficult market conditions.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!